1) McCallum W, Sarnak MJ. Blood pressure target for the dialysis patient. Semin Dial. 2019 ; 32 : 35-40.
2) Hannedouche T, Roth H, Krummel T, et al. Multiphasic effects of blood pressure on survival in hemodialysis patients. Kidney Int. 2016 ; 90 : 674-84.
3) Zager PG, Nikolic J, Brown RH, et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998 ; 54 : 561-9.
4) Myers OB, Adams C, Rohrscheib MR, et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol. 2010 ; 21 : 1970-8.
5) Alborzi P, Patel N, Agawal R, et al. Home blood pressure are of greater prognostic value than hemodialysis unit recording. Clin J Am Soc Nephrol. 2007 ; 2 : 1228-34.
6) Agawal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010 ; 55 : 762-8.
7) 日本透析医学会. 血液透析患者における心血管合併症の評価と治療に関するガイドライン. 透析会誌. 2011 ; 44 : 337-425.
8) Sarafidis PA, Persu A, Agrwal R, et al. Hypertension in dialysis patients : a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group on the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH). J Hypertensions. 2017 ; 35 : 657-76.
9) Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002 ; 287 : 1548-55.
10) Tozawa M, Iseki K, Iseki C, et al. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int. 2002 ; 61 : 717-26.
11) Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002 ; 287 : 1548-55.
12) K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005 ; 45 (Suppl 3) : S1-S153.
13) Davenport A, Cox C, Thuraisingham R. Achieving blood pressure target during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008 ; 73 : 759-64.
14) 日本高血圧学会高血圧治療ガイドライン作成委員会, 編. 高血圧治療ガイドライン 2019. 東京 : ライフサイエンス出版 ; 2019.
15) Heerspink HJ, Ninomiya Y, Zoungas S, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis : a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009 ; 373 : 1009-15.
16) Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients : systematic review and meta-analysis. Hypertension. 2009 ; 53 : 860-6.
17) Agarwal R, Alborzi P, Satyan S, et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP) : a randomized, controlled trial. Hypertension. 2009 ; 53 : 500-7.
18) Georgianos PI, Agawal R. Blood pressure control in conventional hemodialysis. Semin Dial. 2018 ; 31 : 557-62.
19) Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017 ; 28 : 2491-7.
20) 日本透析医学会. 維持血液透析ガイドライン : 血液透析処方. 透析会誌. 2013 ; 46 : 587-632.
21) Assimon MM, Wenger JB, Wang L, et al. Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2016 ; 68 : 911-22.
22) Liu Y, Ma X, Zheng J, et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients : a meta-analysis of randomised controlled trials. BMC Nephrol. 2017 ; 18 : 206.
23) Agarwal R, Sinha AD, Pappas MK, et al. Hypertension in hemodialysis patients treated with atenolol or lisinopril : a randomized controlled trial. Nephrol Dial Transplant. 2014 ; 29 : 672-81.
24) Kuipers J, Verboom LM, Ipema KJR, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis : a systematic review with meta-analysis. Am J Nephrol. 2019 ; 49 : 497-506.
25) Sands JJ, Usvyat LA, Sullivan T, et al. Intradialytic hypotension : frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014 ; 18 : 415-22.
26) Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysis-associated hypotension as an independent risk factor for two-year motality in hemodialysis patients. Kidney Int. 2004 ; 66 : 1212-20.
27) Sars B, van der Sande FM, Kooman JP. Intradialytic hypotension : mechanisms and outcome. Blood Purif. 2019 ; 18 : 1-10.
28) Stefansson BV, Brunelli SM, Cabrera C, et al. Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol. 2014 ; 9 : 2124-32.
29) Flythe JE, Xue H, Lynch KE, et al. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol. 2015 ; 26 : 724-34.
30) Inrig JK, Patel UD, Toto RD, et al. Association blood pressure increase during hemodialysis with 2-year mortality in incident hemodialysis patients : a second analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis. 2009 ; 54 : 881-90.
32) Mclntyre CW, Burton JO, Selby NM, et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008 ; 3 : 19-26.
33) 平田純生, 古久保拓, 編. 昇圧薬. In : 透析患者への投薬ガイドブック-慢性腎臓病 (CKD) の薬物療法-. 改訂3版. 東京 : じほう ; 2017. p.518-21.
34) Nicholas M, McIntyre CW. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant. 2006 ; 21 : 1883-98.
35) Eldehni MT, Odudu A, Mclntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015 ; 26 : 957-65.
36) Maduell F, Moreso F, Pons M, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013 ; 24 : 487-97.
37) Koda Y, Aoike I, Hasegawa S, et al. Feasibility of intermittent, back-filtrate infusion hemodiafiltration to reduce intradialytic hypotension in patients with cardiovascular instability : a pilot study. Clin Exp Nephrol. 2017 ; 21 : 324-32.